Sumant Kulkarni
Stock Analyst at Canaccord Genuity
(0)
# 4692
Out of 5,372 analysts
129
Total ratings
28.00%
Success rate
-15.58%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SAGE Sage Therapeutics | Maintains: Hold | 8 9 | 9.11 | -6.7% | 6 | Jun 17, 2025 | |
ANVS Annovis Bio | Maintains: Buy | 26 17 | 2.64 | 543.94% | 3 | May 15, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 158 160 | 124.84 | 28.16% | 16 | May 6, 2025 | |
BIIB Biogen | Maintains: Buy | 265 220 | 126.62 | 73.75% | 16 | May 2, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 12 21 | 7.05 | 197.87% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | 8.81 | 183.77% | 6 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 12 | 3.11 | 285.85% | 5 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 23 15 | 4.49 | 234.08% | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 73 | 7.71 | 846.82% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 119 132 | n/a | n/a | 5 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 112 80 | 1.62 | 4838.27% | 7 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 28 | 11.97 | 133.92% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 11 | 2.23 | 393.27% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 83 | 4.3 | 1830.23% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 6.71 | 108.64% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 36 | n/a | n/a | 4 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 20 | 11.67 | 71.38% | 3 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 33 | 22.83 | 44.55% | 13 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 2 | n/a | n/a | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 101 150 | 14.58 | 928.81% | 4 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 4 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 110 120 | n/a | n/a | 2 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 31, 2017 |